AI and connected data are reshaping feasibility and site selection across the clinical development lifecycle, allowing ...

PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision ...

“Failure to recruit patients for trials leads to delays in drug development, which are bad both for sponsors and patients,” Sagar Vaidya, Chief Medical Officer of Cerevance during a presentation at ...

75% of patients receiving si-544 experienced objective clinical improvement, of which 44% achieved clear or almost clear skin San Diego, CA, USA, and Munich, Germany – April 29, 2024 - selectION, Inc.

Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...

Thank you for standing by, and welcome to the 4DMedical Investor Webinar. I would now like to hand the conference over to John Hester, Senior Analyst at Bell Potter. Please go ahead. Thank you. Thank ...

BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical ...

As the FDA formally recognizes real-world evidence as eligible confirmatory evidence for drug approval, sponsors face a growing imperative to build the data infrastructure, organizational alignment, ...

An expert interview explores the scientific necessity of patient experience data in amyotrophic lateral sclerosis drug ...

Pancreatic cancer is the third-leading cause of cancer death in the United States, and for patients whose tumors spread after ...

Medicus Pharma (NASDAQ:MDCX) has filed a substantial modification application through the European Union Clinical Trials ...